Good morning, Boston. Here are the five things you need to know in Boston business news to start your day. Black Friday sales deliver U.S. …
An Art Deco condo in Back Bay is on the market for $2.9 million
The building and the unit boast features in the Art Deco style that was popular during its construction in 1920. Get a glimpse inside. Boston …
Amid persistent inflation, innovations in Medicare Advantage can help Massachusetts beneficiaries save money in 2023
The latest economic data show many of us are paying more for essential goods like groceries and fuel, and prices for everyday products continue to …
For Lexington’s UniQure, hemophilia gene therapy approval is a comeback story
For Lexington-based UniQure NV, Hemgenix — the first drug approved by the FDA for hemophilia B — is a comeback story. Boston Biz Journal https://www.bizjournals.com/boston/news/2022/11/23/uniqure-csl-behring-hemgenix-approval.html?ana=RSS&s=article_search
Boston private equity firm HarbourVest closes sixth co-investment fund at $4.2B
The $4.2B will be invested in companies across North America, Europe, Asia-Pacific and select emerging markets. Boston Biz Journal https://www.bizjournals.com/boston/news/2022/11/23/harbourvest-partners-investment-fund.html?ana=RSS&s=article_search
Viewpoint: Private sector is key to landing Biden’s Cancer Moonshot
Brooks Tingle, president and CEO of John Hancock Insurance, calls for increasing access to cancer diagnostic tests. Boston Biz Journal https://www.bizjournals.com/boston/news/2022/11/23/viewpoint-private-sector-is-key-to-landing-biden.html?ana=RSS&s=article_search
Winklevoss twins invest in Boston startup’s new misinformation-combatting search engine
Cameron and Tyler Winklevoss, known in Boston as the identical twins who co-founded a site called HarvardConnection (renamed ConnectU) and then sued Mark Zuckerberg for …
Mass. may beat California for IPOs this year for the first time since 2003
The number of IPOs in the Golden State is down 89% from last year. Boston Biz Journal https://www.bizjournals.com/boston/news/2022/11/23/california-may-not-be-no-1-for-ipos-this-year.html?ana=RSS&s=article_search
Five things you need to know, and why we eat turkey
Good morning, Boston. Here are the five things you need to know in Boston business news to start your day before Thanksgiving. Warren urges Fidelity …
The Petri Dish: J&J vet joins Moderna as U.S. GM; Invivyd partners with investment firm
David Jiménez, a multidecade veteran of Johnson & Johnson who was most recently president of the Janssen immunology division, has joined Moderna to oversee U.S. …